Sonoma Pharmaceuticals, Inc.
SNOA
$2.97
$0.051.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.50% | 26.16% | 40.06% | 19.75% | 6.13% |
| Total Depreciation and Amortization | -21.59% | -12.43% | 2.56% | 22.30% | 40.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.92% | -67.39% | -60.07% | -48.16% | -29.35% |
| Change in Net Operating Assets | 46.25% | 410.98% | 130.10% | 395.51% | 187.72% |
| Cash from Operations | 96.33% | 103.19% | 64.34% | 35.97% | 61.02% |
| Capital Expenditure | -3,900.00% | 92.86% | 94.17% | 103.80% | 99.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,900.00% | 85.29% | 79.10% | 103.97% | 99.22% |
| Total Debt Issued | -26.54% | -27.57% | -25.40% | -27.57% | -27.57% |
| Total Debt Repaid | 16.01% | 14.37% | 19.20% | 30.27% | 46.20% |
| Issuance of Common Stock | 77.19% | -19.82% | 43.17% | -11.47% | -37.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -84.38% | -- |
| Cash from Financing | 80.79% | -22.96% | 44.09% | -10.73% | -32.66% |
| Foreign Exchange rate Adjustments | -2,025.00% | -264.92% | -286.24% | -204.62% | -90.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 424.57% | 1,341.23% | 259.88% | 53.23% | 80.65% |